semaglutide diabetes Rybelsus: What Does It Do and How Do I Use It? Semaglutide and Diabetes: What You

FDA-compliant compounding pharmacies

- What is best practice when someone reaches their goal weight or decides to stop treatment

Stanford Medicine endocrinologist Sun Kim, MD, MS, and bariatric and minimally...

Electronic databases including PubMed, Embase, and Web of Science were searched from inception until August 2025 using keywords such as GLP-1 receptor agonist, diabetic retinopathy, glaucoma, age-related macular degeneration, ocular disease, and neuroprotection. The search focused on identifying preclinical studies, large-scale retrospective cohort studies, and post-hoc analyses of major clinical trials that evaluated the utility and potential mechanisms of GLP-1RAs in ophthalmic diseases

GLP-1RAs provide cardioprotective benefits through glycaemic and non-glycaemic effects, including improved insulin secretion and action, body-weight loss, blood-pressure lowering and improved lipid profile, as well as via direct effects on the heart and vasculature

Pharmaceutical companies are racing to develop a GLP-1 weight-loss drug in pill form